indolactam v has been researched along with Experimental Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, Y; Fujiki, H; Hasegawa, M; Hirota, M; Horiuchi, T; Nakayasu, M; Shudo, K; Suganuma, M; Yoshizawa, S | 1 |
1 other study(ies) available for indolactam v and Experimental Neoplasms
Article | Year |
---|---|
Synthetic analogues (indolactams) of (-)-indolactam-V are new congeners of the teleocidin class of tumor promoters.
Topics: Animals; Cell Adhesion; Cell Line; Dose-Response Relationship, Drug; Enzyme Induction; Humans; Indoles; Lactams; Leukemia, Myeloid, Acute; Lyngbya Toxins; Mice; Neoplasms, Experimental; Ornithine Decarboxylase; Protein Kinase C; Skin; Structure-Activity Relationship; Tetradecanoylphorbol Acetate | 1987 |